Lead sponsor
Inmune Bio, Inc.
4 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
4
Trials led
0
Ongoing
238
Total enrollment
49
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
1
Phase 2
3
Trials by status
Completed
2
Terminated
1
Withdrawn
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
A Biomarker-directed Study of XPro1595 in Patients With Alzheimer'sAlzheimer's diseasePh 1Completed20
An Open-Label Extension of XPro1595 in Patients With Alzheimer's DiseaseStudy partner/caregiver requiredPh 2Terminated11
Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of InflammationAlzheimer's diseasePh 2Withdrawnnot disclosed